dc.creatorFreire, Analia
dc.creatorScaglia, Paula Alejandra
dc.creatorGryngarten, Mirta Graciela
dc.creatorGutiérrez, Mariana Lilián
dc.creatorArcari, Andrea Josefina
dc.creatorSuarez, Laura
dc.creatorBallerini, Maria Gabriela
dc.creatorValinotto, Laura Elena
dc.creatorNatale, Mónica Inés
dc.creatorDel Toro Camargo, Kenny
dc.creatorBergada, Cesar
dc.creatorRey, Rodolfo Alberto
dc.creatorRopelato, Maria Gabriela
dc.date.accessioned2020-11-09T12:43:23Z
dc.date.accessioned2022-10-15T16:45:04Z
dc.date.available2020-11-09T12:43:23Z
dc.date.available2022-10-15T16:45:04Z
dc.date.created2020-11-09T12:43:23Z
dc.date.issued2019-06
dc.identifierFreire, Analia; Scaglia, Paula Alejandra; Gryngarten, Mirta Graciela; Gutiérrez, Mariana Lilián; Arcari, Andrea Josefina; et al.; Type A Insulin Resistance Syndrome- Novel insulin receptor gene mutation and familiar phenotypic variability; Peertechz Publications; International Journal of Clinical Endocrinology and Metabolism; 5; 6-2019; 17-19
dc.identifier2640-7582
dc.identifierhttp://hdl.handle.net/11336/117901
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4410998
dc.description.abstractType A Insulin Resistance Syndrome is due to heterozygous mutations in the insulin receptor (INSR) gene or its signaling pathway. We present a premenarcheal 14 year-old girl with normal BMI, severe hirsutism, acanthosis nigricans, clitoral hypertrophy, deep voice, enlarged polycystic ovaries, severe hyperinsulinemia and biochemical hyperandrogenism.We identifi ed a novel heterozygous missense variant in the tyrosine kinase domain of INSR(p.Leu1150Pro) and an heterozygous missense variant in SH2B adapter protein 1 involved in the insulin pathway (p.Ala663Val). Interestingly, the patients? mother and brother had the same INSR mutation although of a milder phenotype, reason why their IR went  undiagnosed.The novel heterozygous p.Leu1150Pro mutation in the INSR gene appears to be the cause of the type A insulin resistance syndrome; the SH2B1 mutation, likely to synergistically affect the insulin pathway, may contribute to explain the more severe presentation of the phenotype in the patient and the phenotypic variability of the syndrome within this family.
dc.languageeng
dc.publisherPeertechz Publications
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://www.peertechz.com/articles/IJCEM-5-137.php
dc.rightshttps://creativecommons.org/licenses/by/2.5/ar/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectINSULINE RECEPTOR
dc.subjectHYPERANDROGENISM
dc.subjectACANTHOSIS NIGRICANS
dc.titleType A Insulin Resistance Syndrome- Novel insulin receptor gene mutation and familiar phenotypic variability
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución